

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.71946742 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.73798012 |
| 3 | muscle filament sliding (GO:0030049) | 8.73798012 |
| 4 | cardiac myofibril assembly (GO:0055003) | 8.38480355 |
| 5 | myofibril assembly (GO:0030239) | 8.09569826 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.87597695 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 7.48365958 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.35469857 |
| 9 | actin-mediated cell contraction (GO:0070252) | 7.21151451 |
| 10 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.08321824 |
| 11 | plasma membrane repair (GO:0001778) | 7.05847426 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.79208896 |
| 13 | cardiac muscle contraction (GO:0060048) | 6.71933600 |
| 14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.54551054 |
| 15 | cardiac muscle cell development (GO:0055013) | 6.48475181 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.32401614 |
| 17 | actomyosin structure organization (GO:0031032) | 6.17396496 |
| 18 | cardiac cell development (GO:0055006) | 6.09165831 |
| 19 | striated muscle contraction (GO:0006941) | 5.94181865 |
| 20 | regulation of relaxation of muscle (GO:1901077) | 5.87527957 |
| 21 | regulation of actin filament-based movement (GO:1903115) | 5.83753460 |
| 22 | adult heart development (GO:0007512) | 5.78500600 |
| 23 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.75758715 |
| 24 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.64705460 |
| 25 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.63144462 |
| 26 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.60233414 |
| 27 | carnitine shuttle (GO:0006853) | 5.54063216 |
| 28 | tricarboxylic acid cycle (GO:0006099) | 5.51961285 |
| 29 | actin filament-based movement (GO:0030048) | 5.48632143 |
| 30 | cardiac muscle hypertrophy (GO:0003300) | 5.43630295 |
| 31 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.42435486 |
| 32 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.22660001 |
| 33 | striated muscle hypertrophy (GO:0014897) | 5.20971918 |
| 34 | skeletal muscle fiber development (GO:0048741) | 5.17259154 |
| 35 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.16245296 |
| 36 | muscle tissue morphogenesis (GO:0060415) | 5.16158585 |
| 37 | regulation of cell communication by electrical coupling (GO:0010649) | 5.14966540 |
| 38 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.05186242 |
| 39 | skeletal muscle contraction (GO:0003009) | 5.02917892 |
| 40 | regulation of striated muscle contraction (GO:0006942) | 5.02221543 |
| 41 | myotube cell development (GO:0014904) | 4.94710376 |
| 42 | regulation of sarcomere organization (GO:0060297) | 4.90874433 |
| 43 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.88830588 |
| 44 | fatty acid transmembrane transport (GO:1902001) | 4.70777537 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.67866086 |
| 46 | heart process (GO:0003015) | 4.63682417 |
| 47 | heart contraction (GO:0060047) | 4.63682417 |
| 48 | regulation of membrane repolarization (GO:0060306) | 4.60016755 |
| 49 | heart trabecula formation (GO:0060347) | 4.59849778 |
| 50 | muscle hypertrophy (GO:0014896) | 4.59610865 |
| 51 | regulation of the force of heart contraction (GO:0002026) | 4.45726637 |
| 52 | cell communication involved in cardiac conduction (GO:0086065) | 4.44200411 |
| 53 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.42874450 |
| 54 | skeletal muscle tissue regeneration (GO:0043403) | 4.16544120 |
| 55 | skeletal muscle tissue development (GO:0007519) | 4.15225041 |
| 56 | carnitine transmembrane transport (GO:1902603) | 4.13107468 |
| 57 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.10725148 |
| 58 | muscle contraction (GO:0006936) | 4.10258008 |
| 59 | response to inactivity (GO:0014854) | 4.09975356 |
| 60 | muscle cell fate commitment (GO:0042693) | 4.03835429 |
| 61 | cardiac muscle cell action potential (GO:0086001) | 4.03385172 |
| 62 | striated muscle cell development (GO:0055002) | 4.03332191 |
| 63 | creatine metabolic process (GO:0006600) | 4.02267606 |
| 64 | regulation of coenzyme metabolic process (GO:0051196) | 4.01369805 |
| 65 | regulation of cofactor metabolic process (GO:0051193) | 4.01369805 |
| 66 | skeletal muscle adaptation (GO:0043501) | 4.01175176 |
| 67 | cell communication by electrical coupling (GO:0010644) | 3.99207446 |
| 68 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.97477424 |
| 69 | muscle cell cellular homeostasis (GO:0046716) | 3.95722070 |
| 70 | regulation of cardiac muscle contraction (GO:0055117) | 3.95443476 |
| 71 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.89620274 |
| 72 | regulation of heart rate (GO:0002027) | 3.88911162 |
| 73 | muscle adaptation (GO:0043500) | 3.87148440 |
| 74 | negative regulation of protein localization to cell surface (GO:2000009) | 3.83658651 |
| 75 | negative regulation of potassium ion transport (GO:0043267) | 3.82753572 |
| 76 | muscle system process (GO:0003012) | 3.77996869 |
| 77 | muscle atrophy (GO:0014889) | 3.77134683 |
| 78 | amino-acid betaine transport (GO:0015838) | 3.76218280 |
| 79 | carnitine transport (GO:0015879) | 3.76218280 |
| 80 | regulation of ATPase activity (GO:0043462) | 3.74108666 |
| 81 | regulation of ATP catabolic process (GO:1903289) | 3.74108666 |
| 82 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.69920478 |
| 83 | striated muscle adaptation (GO:0014888) | 3.68077736 |
| 84 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.66144341 |
| 85 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.65295311 |
| 86 | muscle hypertrophy in response to stress (GO:0003299) | 3.65295311 |
| 87 | cardiac muscle adaptation (GO:0014887) | 3.65295311 |
| 88 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.63197534 |
| 89 | regulation of muscle system process (GO:0090257) | 3.60392742 |
| 90 | regulation of heart contraction (GO:0008016) | 3.58021095 |
| 91 | positive regulation of cation channel activity (GO:2001259) | 3.57934867 |
| 92 | muscle organ development (GO:0007517) | 3.54573474 |
| 93 | muscle structure development (GO:0061061) | 3.53264806 |
| 94 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.51409126 |
| 95 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.51409126 |
| 96 | cardiac chamber formation (GO:0003207) | 3.48966326 |
| 97 | positive regulation of myotube differentiation (GO:0010831) | 3.48193487 |
| 98 | regulation of myoblast differentiation (GO:0045661) | 3.45740797 |
| 99 | muscle cell development (GO:0055001) | 3.45654441 |
| 100 | glycogen biosynthetic process (GO:0005978) | 3.43582146 |
| 101 | glucan biosynthetic process (GO:0009250) | 3.43582146 |
| 102 | muscle fiber development (GO:0048747) | 3.42499774 |
| 103 | regulation of muscle contraction (GO:0006937) | 3.41820463 |
| 104 | relaxation of cardiac muscle (GO:0055119) | 3.39738328 |
| 105 | 2-oxoglutarate metabolic process (GO:0006103) | 3.39195210 |
| 106 | striated muscle atrophy (GO:0014891) | 3.37136602 |
| 107 | oxygen transport (GO:0015671) | 3.36804550 |
| 108 | response to caffeine (GO:0031000) | 3.35240345 |
| 109 | NADH metabolic process (GO:0006734) | 3.33793493 |
| 110 | glucan catabolic process (GO:0009251) | 3.32997840 |
| 111 | cardiac conduction (GO:0061337) | 3.32528442 |
| 112 | regulation of cardioblast differentiation (GO:0051890) | 3.31168226 |
| 113 | positive regulation of heart rate (GO:0010460) | 3.30385486 |
| 114 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.29705270 |
| 115 | glycogen catabolic process (GO:0005980) | 3.29200449 |
| 116 | response to muscle activity (GO:0014850) | 3.26137351 |
| 117 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.25716464 |
| 118 | regulation of sulfur metabolic process (GO:0042762) | 3.24824554 |
| 119 | striated muscle tissue development (GO:0014706) | 3.24632381 |
| 120 | regulation of sequestering of triglyceride (GO:0010889) | 3.24365439 |
| 121 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.24084256 |
| 122 | positive regulation of myoblast differentiation (GO:0045663) | 3.23997398 |
| 123 | positive regulation of heart contraction (GO:0045823) | 3.23478106 |
| 124 | cardiac ventricle formation (GO:0003211) | 3.15022576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.44766795 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.46633063 |
| 3 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.05128925 |
| 4 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.05128925 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.69260824 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.61739495 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.37656084 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.36150474 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.35442314 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.15410054 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.08559529 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.68767341 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.47309527 |
| 14 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.26290960 |
| 15 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.22022294 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.21159078 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.12846127 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.07735630 |
| 19 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.06693665 |
| 20 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.95704217 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94087343 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.91769598 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82289490 |
| 24 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.75544797 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69912136 |
| 26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.65111460 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.65079159 |
| 28 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.63064737 |
| 29 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.62919612 |
| 30 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.50887137 |
| 31 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.46932678 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.46007424 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42535580 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41214212 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41022555 |
| 36 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.39308033 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38949895 |
| 38 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.38869824 |
| 39 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34344622 |
| 40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.28864300 |
| 41 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.27778284 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27618158 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27157996 |
| 44 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24334722 |
| 45 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24192534 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23168647 |
| 47 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21485473 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21047605 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20630433 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20205945 |
| 51 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19931545 |
| 52 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.19656697 |
| 53 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.19375607 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17728924 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17548365 |
| 56 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15011873 |
| 57 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12469619 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11510637 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11368942 |
| 60 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.11166352 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10740896 |
| 62 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10373600 |
| 63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09913802 |
| 64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07443501 |
| 65 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06410102 |
| 66 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06314472 |
| 67 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.05939294 |
| 68 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.04830403 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04761159 |
| 70 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03947921 |
| 71 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03617938 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03130223 |
| 73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03122593 |
| 74 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02562194 |
| 75 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02552823 |
| 76 | P68_20966046_ChIP-Seq_HELA_Human | 1.02415058 |
| 77 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02270223 |
| 78 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00649500 |
| 79 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.00013718 |
| 80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.99848515 |
| 81 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99472338 |
| 82 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99098179 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98576481 |
| 84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98576481 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97863066 |
| 86 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97302763 |
| 87 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96776010 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96412735 |
| 89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96324448 |
| 90 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.95634783 |
| 91 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.95516907 |
| 92 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95343130 |
| 93 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.95156668 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94895607 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94501337 |
| 96 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94355999 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93429742 |
| 98 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93211187 |
| 99 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.93187757 |
| 100 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.92744955 |
| 101 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91319023 |
| 102 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.91281085 |
| 103 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90823974 |
| 104 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.90762610 |
| 105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89447677 |
| 106 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.88609999 |
| 107 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.88370565 |
| 108 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88227182 |
| 109 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88186046 |
| 110 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87863804 |
| 111 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87468679 |
| 112 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.86546375 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86207916 |
| 114 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85850705 |
| 115 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85318462 |
| 116 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.84312567 |
| 117 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84193424 |
| 118 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.84104054 |
| 119 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.83614200 |
| 120 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.83577558 |
| 121 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.82933641 |
| 122 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.82858973 |
| 123 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81988381 |
| 124 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.81923031 |
| 125 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.81572230 |
| 126 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81560384 |
| 127 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81446539 |
| 128 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81296228 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80599332 |
| 130 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80115602 |
| 131 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79710080 |
| 132 | TBL1_22424771_ChIP-Seq_293T_Human | 0.79683090 |
| 133 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.79427502 |
| 134 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.79186396 |
| 135 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.79099257 |
| 136 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.78904100 |
| 137 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.77791458 |
| 138 | AR_19668381_ChIP-Seq_PC3_Human | 0.77703550 |
| 139 | * GF1_26923725_Chip-Seq_HPCs_Mouse | 0.76278547 |
| 140 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75848209 |
| 141 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.75511072 |
| 142 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75464457 |
| 143 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.75150044 |
| 144 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.72483334 |
| 145 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.72249209 |
| 146 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71532491 |
| 147 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.71238154 |
| 148 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.70945824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.72263677 |
| 2 | MP0003646_muscle_fatigue | 5.65874892 |
| 3 | MP0000751_myopathy | 5.58383085 |
| 4 | MP0004084_abnormal_cardiac_muscle | 5.32183273 |
| 5 | MP0000749_muscle_degeneration | 4.49614757 |
| 6 | MP0004215_abnormal_myocardial_fiber | 4.48010845 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.28433296 |
| 8 | MP0005330_cardiomyopathy | 3.79064642 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.45329834 |
| 10 | * MP0004087_abnormal_muscle_fiber | 3.26091522 |
| 11 | MP0000750_abnormal_muscle_regeneration | 3.02977658 |
| 12 | MP0002106_abnormal_muscle_physiology | 2.95254535 |
| 13 | MP0002972_abnormal_cardiac_muscle | 2.93717821 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.84446210 |
| 15 | MP0003137_abnormal_impulse_conducting | 2.78721381 |
| 16 | MP0002269_muscular_atrophy | 2.68819905 |
| 17 | MP0008775_abnormal_heart_ventricle | 2.63935373 |
| 18 | MP0004130_abnormal_muscle_cell | 2.51684703 |
| 19 | * MP0010630_abnormal_cardiac_muscle | 2.50158399 |
| 20 | MP0000747_muscle_weakness | 2.49974528 |
| 21 | MP0005385_cardiovascular_system_phenoty | 2.40601139 |
| 22 | MP0001544_abnormal_cardiovascular_syste | 2.40601139 |
| 23 | MP0005369_muscle_phenotype | 2.40533340 |
| 24 | MP0000759_abnormal_skeletal_muscle | 2.35994820 |
| 25 | MP0004484_altered_response_of | 2.27336195 |
| 26 | MP0006138_congestive_heart_failure | 2.11196443 |
| 27 | MP0004510_myositis | 2.08143164 |
| 28 | MP0003828_pulmonary_edema | 2.06161176 |
| 29 | MP0004233_abnormal_muscle_weight | 2.03514313 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.92149739 |
| 31 | MP0004085_abnormal_heartbeat | 1.86349182 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.74020490 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 1.62842922 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.52591737 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.49097840 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.46076852 |
| 37 | MP0005670_abnormal_white_adipose | 1.37829217 |
| 38 | MP0004270_analgesia | 1.34428572 |
| 39 | MP0001661_extended_life_span | 1.34255413 |
| 40 | MP0003567_abnormal_fetal_cardiomyocyte | 1.26542251 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.15543778 |
| 42 | * MP0000266_abnormal_heart_morphology | 1.09906834 |
| 43 | MP0004185_abnormal_adipocyte_glucose | 1.08585160 |
| 44 | MP0000733_abnormal_muscle_development | 1.08494412 |
| 45 | MP0000343_altered_response_to | 1.06296812 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.02045659 |
| 47 | MP0002234_abnormal_pharynx_morphology | 1.00119564 |
| 48 | MP0003279_aneurysm | 0.95759232 |
| 49 | MP0010368_abnormal_lymphatic_system | 0.94081676 |
| 50 | MP0005165_increased_susceptibility_to | 0.88045139 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 0.84721007 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 0.83812836 |
| 53 | MP0005266_abnormal_metabolism | 0.81651375 |
| 54 | MP0003566_abnormal_cell_adhesion | 0.74588512 |
| 55 | MP0005623_abnormal_meninges_morphology | 0.73402961 |
| 56 | * MP0002128_abnormal_blood_circulation | 0.71998019 |
| 57 | MP0002971_abnormal_brown_adipose | 0.68257104 |
| 58 | MP0000013_abnormal_adipose_tissue | 0.68017864 |
| 59 | MP0000230_abnormal_systemic_arterial | 0.61349212 |
| 60 | MP0003045_fibrosis | 0.60592076 |
| 61 | MP0000003_abnormal_adipose_tissue | 0.59404840 |
| 62 | MP0000767_abnormal_smooth_muscle | 0.57589467 |
| 63 | MP0005451_abnormal_body_composition | 0.54253665 |
| 64 | MP0001879_abnormal_lymphatic_vessel | 0.49379955 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 0.48906433 |
| 66 | MP0002909_abnormal_adrenal_gland | 0.47078788 |
| 67 | MP0008438_abnormal_cutaneous_collagen | 0.46255716 |
| 68 | MP0005275_abnormal_skin_tensile | 0.45923643 |
| 69 | * MP0002925_abnormal_cardiovascular_devel | 0.44291775 |
| 70 | MP0004272_abnormal_basement_membrane | 0.43694210 |
| 71 | MP0000372_irregular_coat_pigmentation | 0.42220605 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.41949161 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 0.41546001 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 0.41378302 |
| 75 | MP0005187_abnormal_penis_morphology | 0.39797746 |
| 76 | MP0002822_catalepsy | 0.38378731 |
| 77 | MP0003984_embryonic_growth_retardation | 0.37646122 |
| 78 | MP0004134_abnormal_chest_morphology | 0.37427800 |
| 79 | MP0004043_abnormal_pH_regulation | 0.36998804 |
| 80 | MP0003879_abnormal_hair_cell | 0.36631174 |
| 81 | MP0002088_abnormal_embryonic_growth/wei | 0.36468594 |
| 82 | MP0003948_abnormal_gas_homeostasis | 0.34552440 |
| 83 | * MP0001784_abnormal_fluid_regulation | 0.33814571 |
| 84 | MP0008569_lethality_at_weaning | 0.33439565 |
| 85 | MP0005334_abnormal_fat_pad | 0.31996883 |
| 86 | * MP0001614_abnormal_blood_vessel | 0.31426632 |
| 87 | MP0009115_abnormal_fat_cell | 0.30545404 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.30038021 |
| 89 | MP0004147_increased_porphyrin_level | 0.29321201 |
| 90 | MP0006276_abnormal_autonomic_nervous | 0.25793264 |
| 91 | MP0002114_abnormal_axial_skeleton | 0.25602232 |
| 92 | MP0000579_abnormal_nail_morphology | 0.25504612 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.25232592 |
| 94 | MP0001849_ear_inflammation | 0.24248847 |
| 95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.22783582 |
| 96 | MP0004142_abnormal_muscle_tone | 0.21708343 |
| 97 | MP0005535_abnormal_body_temperature | 0.21665775 |
| 98 | MP0009780_abnormal_chondrocyte_physiolo | 0.21032254 |
| 99 | MP0001529_abnormal_vocalization | 0.20521465 |
| 100 | MP0003385_abnormal_body_wall | 0.19812639 |
| 101 | MP0005452_abnormal_adipose_tissue | 0.19573910 |
| 102 | MP0005595_abnormal_vascular_smooth | 0.19496277 |
| 103 | MP0009250_abnormal_appendicular_skeleto | 0.19390622 |
| 104 | MP0010030_abnormal_orbit_morphology | 0.19221580 |
| 105 | MP0002970_abnormal_white_adipose | 0.19122349 |
| 106 | MP0005380_embryogenesis_phenotype | 0.18934675 |
| 107 | MP0001672_abnormal_embryogenesis/_devel | 0.18934675 |
| 108 | MP0009672_abnormal_birth_weight | 0.18399356 |
| 109 | MP0001943_abnormal_respiration | 0.17735129 |
| 110 | MP0002638_abnormal_pupillary_reflex | 0.17607348 |
| 111 | MP0001727_abnormal_embryo_implantation | 0.16518112 |
| 112 | MP0002896_abnormal_bone_mineralization | 0.16057624 |
| 113 | MP0001299_abnormal_eye_distance/ | 0.15871831 |
| 114 | MP0002118_abnormal_lipid_homeostasis | 0.15714973 |
| 115 | MP0000249_abnormal_blood_vessel | 0.15475530 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.14030762 |
| 117 | MP0003941_abnormal_skin_development | 0.13865131 |
| 118 | MP0000762_abnormal_tongue_morphology | 0.13553879 |
| 119 | MP0001958_emphysema | 0.12992236 |
| 120 | MP0008874_decreased_physiological_sensi | 0.12852918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.13224883 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 6.79713324 |
| 3 | Exercise-induced myalgia (HP:0003738) | 6.77703087 |
| 4 | Muscle fiber splitting (HP:0003555) | 6.51335298 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.47845774 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 6.43419588 |
| 7 | Ventricular tachycardia (HP:0004756) | 6.34041580 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 5.67191116 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.59475834 |
| 10 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.39962016 |
| 11 | Subaortic stenosis (HP:0001682) | 5.39962016 |
| 12 | Atrial fibrillation (HP:0005110) | 5.39240051 |
| 13 | Primary atrial arrhythmia (HP:0001692) | 5.03892463 |
| 14 | Lipoatrophy (HP:0100578) | 5.00805626 |
| 15 | EMG: myopathic abnormalities (HP:0003458) | 4.86819915 |
| 16 | Supraventricular tachycardia (HP:0004755) | 4.86574499 |
| 17 | Muscle fiber inclusion bodies (HP:0100299) | 4.85886082 |
| 18 | Myoglobinuria (HP:0002913) | 4.85345059 |
| 19 | Supraventricular arrhythmia (HP:0005115) | 4.77341802 |
| 20 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.76510187 |
| 21 | Right ventricular cardiomyopathy (HP:0011663) | 4.69136631 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 4.64536888 |
| 23 | Increased connective tissue (HP:0009025) | 4.52398550 |
| 24 | Syncope (HP:0001279) | 4.40994534 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 4.31679412 |
| 26 | Difficulty running (HP:0009046) | 4.27653973 |
| 27 | Dilated cardiomyopathy (HP:0001644) | 4.18539033 |
| 28 | Bundle branch block (HP:0011710) | 4.18236586 |
| 29 | Prolonged QT interval (HP:0001657) | 4.06221949 |
| 30 | Nemaline bodies (HP:0003798) | 3.99711938 |
| 31 | Myotonia (HP:0002486) | 3.83905239 |
| 32 | Palpitations (HP:0001962) | 3.83259441 |
| 33 | Ventricular arrhythmia (HP:0004308) | 3.82551318 |
| 34 | Rhabdomyolysis (HP:0003201) | 3.76760378 |
| 35 | Heart block (HP:0012722) | 3.49474739 |
| 36 | Difficulty climbing stairs (HP:0003551) | 3.47088464 |
| 37 | Atrioventricular block (HP:0001678) | 3.35878832 |
| 38 | Ventricular fibrillation (HP:0001663) | 3.32624907 |
| 39 | Abnormal atrioventricular conduction (HP:0005150) | 3.30349194 |
| 40 | Malignant hyperthermia (HP:0002047) | 3.24211926 |
| 41 | Neck muscle weakness (HP:0000467) | 3.16868221 |
| 42 | Absent phalangeal crease (HP:0006109) | 3.08703114 |
| 43 | Distal arthrogryposis (HP:0005684) | 3.06902857 |
| 44 | Fetal akinesia sequence (HP:0001989) | 3.03466618 |
| 45 | Deformed tarsal bones (HP:0008119) | 3.00671334 |
| 46 | Muscle stiffness (HP:0003552) | 2.98726878 |
| 47 | Abnormal EKG (HP:0003115) | 2.94520322 |
| 48 | Increased variability in muscle fiber diameter (HP:0003557) | 2.92765844 |
| 49 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.89591887 |
| 50 | Areflexia of lower limbs (HP:0002522) | 2.83596559 |
| 51 | Round ear (HP:0100830) | 2.81189018 |
| 52 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.68944773 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.67002312 |
| 54 | Left ventricular hypertrophy (HP:0001712) | 2.65708972 |
| 55 | Myopathic facies (HP:0002058) | 2.63261869 |
| 56 | Weak cry (HP:0001612) | 2.63171362 |
| 57 | Abnormal finger flexion creases (HP:0006143) | 2.60040004 |
| 58 | Rimmed vacuoles (HP:0003805) | 2.59232545 |
| 59 | Popliteal pterygium (HP:0009756) | 2.57513530 |
| 60 | EMG: neuropathic changes (HP:0003445) | 2.54050052 |
| 61 | Palmoplantar keratoderma (HP:0000982) | 2.47017893 |
| 62 | Hypoplastic ischia (HP:0003175) | 2.43592522 |
| 63 | Testicular atrophy (HP:0000029) | 2.39797287 |
| 64 | Limb-girdle muscle atrophy (HP:0003797) | 2.38091769 |
| 65 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.37747309 |
| 66 | Type 2 muscle fiber atrophy (HP:0003554) | 2.35502647 |
| 67 | Generalized muscle weakness (HP:0003324) | 2.31622867 |
| 68 | Distal lower limb amyotrophy (HP:0008944) | 2.30994603 |
| 69 | Gowers sign (HP:0003391) | 2.30202867 |
| 70 | Muscular dystrophy (HP:0003560) | 2.30119595 |
| 71 | Scapular winging (HP:0003691) | 2.24243398 |
| 72 | Ketoacidosis (HP:0001993) | 2.22475108 |
| 73 | Facial diplegia (HP:0001349) | 2.21092536 |
| 74 | Ulnar deviation of the wrist (HP:0003049) | 2.19619206 |
| 75 | Abnormality of the foot musculature (HP:0001436) | 2.16102500 |
| 76 | Muscle fiber atrophy (HP:0100295) | 2.13067021 |
| 77 | Abnormality of the ischium (HP:0003174) | 2.11476512 |
| 78 | Slender build (HP:0001533) | 2.09570761 |
| 79 | Waddling gait (HP:0002515) | 2.07886278 |
| 80 | Frequent falls (HP:0002359) | 2.06574398 |
| 81 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.04658817 |
| 82 | Hyperkalemia (HP:0002153) | 2.01957122 |
| 83 | Hepatic necrosis (HP:0002605) | 2.00753691 |
| 84 | Hip contracture (HP:0003273) | 1.99836466 |
| 85 | Foot dorsiflexor weakness (HP:0009027) | 1.99691392 |
| 86 | Proximal amyotrophy (HP:0007126) | 1.98305222 |
| 87 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.97760936 |
| 88 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.97381415 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 1.97272373 |
| 90 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.97269854 |
| 91 | Abnormality of the calcaneus (HP:0008364) | 1.96442586 |
| 92 | Sudden cardiac death (HP:0001645) | 1.96426008 |
| 93 | Progressive muscle weakness (HP:0003323) | 1.93834175 |
| 94 | Large for gestational age (HP:0001520) | 1.93509332 |
| 95 | Acute necrotizing encephalopathy (HP:0006965) | 1.90497838 |
| 96 | Hypoglycemic coma (HP:0001325) | 1.89082601 |
| 97 | Nonprogressive disorder (HP:0003680) | 1.84048570 |
| 98 | Dysmetric saccades (HP:0000641) | 1.83659524 |
| 99 | Congestive heart failure (HP:0001635) | 1.82640245 |
| 100 | Fatigable weakness (HP:0003473) | 1.80882812 |
| 101 | Abnormality of the neuromuscular junction (HP:0003398) | 1.80882812 |
| 102 | Bulbar palsy (HP:0001283) | 1.80425483 |
| 103 | Increased muscle lipid content (HP:0009058) | 1.80368110 |
| 104 | Abnormality of placental membranes (HP:0011409) | 1.78263168 |
| 105 | Amniotic constriction ring (HP:0009775) | 1.78263168 |
| 106 | Spinal rigidity (HP:0003306) | 1.78112639 |
| 107 | Lower limb amyotrophy (HP:0007210) | 1.77627707 |
| 108 | Aplasia of the musculature (HP:0100854) | 1.76384798 |
| 109 | Conjunctival hamartoma (HP:0100780) | 1.73832931 |
| 110 | Long clavicles (HP:0000890) | 1.71454819 |
| 111 | Hepatocellular necrosis (HP:0001404) | 1.71146403 |
| 112 | Steppage gait (HP:0003376) | 1.70916236 |
| 113 | Diaphragmatic weakness (HP:0009113) | 1.70613145 |
| 114 | Exercise intolerance (HP:0003546) | 1.68642756 |
| 115 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.68031774 |
| 116 | Dicarboxylic aciduria (HP:0003215) | 1.68031774 |
| 117 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.66214001 |
| 118 | Limb-girdle muscle weakness (HP:0003325) | 1.66195640 |
| 119 | Calcaneovalgus deformity (HP:0001848) | 1.65573251 |
| 120 | Easy fatigability (HP:0003388) | 1.65547001 |
| 121 | Limited hip movement (HP:0008800) | 1.63350438 |
| 122 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.62423591 |
| 123 | Acute encephalopathy (HP:0006846) | 1.61835814 |
| 124 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.61141688 |
| 125 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.61141688 |
| 126 | Shoulder girdle muscle weakness (HP:0003547) | 1.58930228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.67074519 |
| 2 | TTN | 5.69211536 |
| 3 | PHKG2 | 4.34033296 |
| 4 | PHKG1 | 4.34033296 |
| 5 | DMPK | 3.29942152 |
| 6 | PDK3 | 3.02783650 |
| 7 | PDK4 | 3.02783650 |
| 8 | LMTK2 | 2.93717685 |
| 9 | MYLK | 2.85268004 |
| 10 | MUSK | 2.70791787 |
| 11 | TRIB3 | 2.68679187 |
| 12 | PKN2 | 2.53898988 |
| 13 | PIK3CA | 2.16183334 |
| 14 | PINK1 | 2.09174012 |
| 15 | NEK1 | 2.03449744 |
| 16 | BCKDK | 1.90964769 |
| 17 | PDK2 | 1.82094801 |
| 18 | TIE1 | 1.66639053 |
| 19 | STK24 | 1.55947050 |
| 20 | CCNB1 | 1.44931629 |
| 21 | ZAK | 1.32881505 |
| 22 | MAP3K7 | 1.29430384 |
| 23 | PIK3CG | 1.26455925 |
| 24 | MAP2K3 | 1.21717914 |
| 25 | PRKD1 | 1.18190832 |
| 26 | NME1 | 1.17660954 |
| 27 | MAPK12 | 1.17401832 |
| 28 | ILK | 1.16260167 |
| 29 | CAMK2D | 1.16183279 |
| 30 | ICK | 1.15950491 |
| 31 | MARK1 | 1.15577710 |
| 32 | EEF2K | 1.12867003 |
| 33 | GRK7 | 1.03912359 |
| 34 | INSRR | 1.03654889 |
| 35 | PAK3 | 0.98591273 |
| 36 | LIMK1 | 0.97534088 |
| 37 | TRPM7 | 0.96506222 |
| 38 | CDC42BPA | 0.95679793 |
| 39 | PRKAA1 | 0.95630392 |
| 40 | MAPKAPK3 | 0.94237966 |
| 41 | PRKAA2 | 0.91491395 |
| 42 | RIPK1 | 0.89685683 |
| 43 | ROCK1 | 0.89044873 |
| 44 | MOS | 0.88098857 |
| 45 | MAP3K5 | 0.84138643 |
| 46 | PDGFRA | 0.78366940 |
| 47 | EPHB1 | 0.76499317 |
| 48 | MAP3K3 | 0.74516879 |
| 49 | PKN1 | 0.74138779 |
| 50 | STK4 | 0.73453981 |
| 51 | TGFBR2 | 0.70010388 |
| 52 | KSR2 | 0.66417072 |
| 53 | WNK4 | 0.66097087 |
| 54 | MAP2K1 | 0.63005725 |
| 55 | SIK1 | 0.62399246 |
| 56 | FLT3 | 0.61639577 |
| 57 | STK38L | 0.60919062 |
| 58 | STK38 | 0.60198701 |
| 59 | MAPK4 | 0.57881673 |
| 60 | CAMK4 | 0.57469437 |
| 61 | RPS6KC1 | 0.55384602 |
| 62 | RPS6KL1 | 0.55384602 |
| 63 | PTK2B | 0.51420384 |
| 64 | AKT2 | 0.51013592 |
| 65 | DAPK3 | 0.49890279 |
| 66 | WNK1 | 0.48420227 |
| 67 | ROCK2 | 0.47287647 |
| 68 | CAMK2A | 0.46593503 |
| 69 | PRKACB | 0.46404510 |
| 70 | RPS6KA6 | 0.45862533 |
| 71 | EPHA3 | 0.44925737 |
| 72 | MAP3K13 | 0.44556894 |
| 73 | CAMK2B | 0.43760206 |
| 74 | MAP3K10 | 0.40914324 |
| 75 | ERBB3 | 0.39886255 |
| 76 | PTK6 | 0.38769970 |
| 77 | MTOR | 0.37226670 |
| 78 | CAMK1 | 0.35663272 |
| 79 | PRKACA | 0.35038264 |
| 80 | MARK2 | 0.34939902 |
| 81 | MAP3K11 | 0.34509200 |
| 82 | CAMK2G | 0.34474192 |
| 83 | KDR | 0.34104786 |
| 84 | PRKACG | 0.33044460 |
| 85 | PRKD3 | 0.32998736 |
| 86 | DYRK1B | 0.32122573 |
| 87 | PDPK1 | 0.31046143 |
| 88 | MAP3K6 | 0.30095746 |
| 89 | SGK2 | 0.29887646 |
| 90 | MAPK11 | 0.29762751 |
| 91 | LATS1 | 0.28754295 |
| 92 | MAP2K6 | 0.28590353 |
| 93 | NLK | 0.27898340 |
| 94 | RPS6KA1 | 0.27781255 |
| 95 | RPS6KB2 | 0.27280648 |
| 96 | NEK9 | 0.26828172 |
| 97 | RPS6KB1 | 0.26335295 |
| 98 | CAMK1G | 0.25603335 |
| 99 | PDK1 | 0.25167356 |
| 100 | LATS2 | 0.24634742 |
| 101 | MAPK10 | 0.24620543 |
| 102 | PRKG1 | 0.24204021 |
| 103 | PRKCE | 0.24099258 |
| 104 | TAOK1 | 0.23328647 |
| 105 | RAF1 | 0.22577727 |
| 106 | MAP2K4 | 0.22281126 |
| 107 | SGK1 | 0.21354489 |
| 108 | PRKD2 | 0.20268390 |
| 109 | ZAP70 | 0.20097092 |
| 110 | RPS6KA3 | 0.19876277 |
| 111 | STK11 | 0.19247542 |
| 112 | PRKCH | 0.18496527 |
| 113 | FGFR3 | 0.18472545 |
| 114 | MAPK7 | 0.17611059 |
| 115 | CAMK1D | 0.16787857 |
| 116 | JAK1 | 0.14286184 |
| 117 | SGK3 | 0.14019687 |
| 118 | PDGFRB | 0.13918371 |
| 119 | EPHB2 | 0.13040000 |
| 120 | FER | 0.11192439 |
| 121 | RPS6KA2 | 0.11100441 |
| 122 | IRAK3 | 0.09870101 |
| 123 | RET | 0.09702845 |
| 124 | MAP3K1 | 0.09188823 |
| 125 | STK39 | 0.08118787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.42083898 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.53887138 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.36066405 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.31651931 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.10444667 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.09594544 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.03765391 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.88271067 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.55812663 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51045897 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.38066518 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.27447287 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.12219181 |
| 14 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.03882308 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.00195502 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.94052698 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.82828498 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.81713782 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58059239 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.52601260 |
| 21 | Insulin resistance_Homo sapiens_hsa04931 | 1.33342368 |
| 22 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.31975029 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29370164 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.27062340 |
| 25 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.20876121 |
| 26 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.18061504 |
| 27 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.15469456 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15278308 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.14312370 |
| 30 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.00743315 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99996646 |
| 32 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.98034150 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 0.97756198 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97581455 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97572251 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.94522914 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94107251 |
| 38 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.94096487 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 0.92507709 |
| 40 | Tight junction_Homo sapiens_hsa04530 | 0.86053959 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81470732 |
| 42 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77916400 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 0.77658065 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73605152 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73498493 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73324633 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72196240 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71518215 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68759939 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65565986 |
| 51 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65349040 |
| 52 | Adherens junction_Homo sapiens_hsa04520 | 0.64782072 |
| 53 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63895638 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61854125 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60335529 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58296649 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.57839756 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57717315 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.57668500 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54565290 |
| 61 | Insulin secretion_Homo sapiens_hsa04911 | 0.53367363 |
| 62 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53161845 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.51021277 |
| 64 | Salivary secretion_Homo sapiens_hsa04970 | 0.50909518 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49028861 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46264934 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44606046 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42609976 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.41777716 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39506978 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39003035 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.36364556 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36158992 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.35220886 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34436289 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34309669 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33437762 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32294313 |
| 79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30380556 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30036602 |
| 81 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28407754 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26655277 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.26396247 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.25958438 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25420400 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25158143 |
| 87 | Melanogenesis_Homo sapiens_hsa04916 | 0.24642007 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.24036101 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.23886193 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.23553684 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23364456 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22977283 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.20235739 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18854199 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.18853208 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.18460468 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18336551 |
| 98 | GABAergic synapse_Homo sapiens_hsa04727 | 0.17549142 |
| 99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.17356708 |
| 100 | Long-term depression_Homo sapiens_hsa04730 | 0.16864040 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.16569480 |
| 102 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.16171650 |
| 103 | Gap junction_Homo sapiens_hsa04540 | 0.15111564 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.14055594 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.13945054 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12447291 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.10320762 |
| 108 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.09206938 |
| 109 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.09123477 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.07605561 |
| 111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06936903 |
| 112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.06399376 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.06329846 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.05066553 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.04058391 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.03536938 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.02814483 |
| 118 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.02715569 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.01931953 |

